Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2020-11-02

AUTHORS

Sarina C. Lowe, Jenny S. Sauk, Berkeley N. Limketkai, Mary R. Kwaan

ABSTRACT

BackgroundMedical therapy for inflammatory bowel disease (IBD) has markedly advanced since the introduction of biologic therapeutics, although surgery remains an important therapeutic strategy for both Crohn’s disease (CD) and ulcerative colitis (UC). This study evaluated how rates of bowel resection surgery and post-operative mortality for IBD have changed over the last decade in the era of biologic therapies.MethodsThe Nationwide Readmission Database (NRD) was queried for patients with IBD (based on ICD-9 and -10 diagnosis and procedure codes) who were hospitalized between 2010 and 2017. Longitudinal trends in bowel resection surgery, urgent surgery, and post-operative mortality were analyzed.ResultsDuring the 8-year period, a total of 1795,266 IBD-related hospitalizations (1,072,110 with CD and 723,156 with UC) were evaluated. There was an increase in the annual number of IBD patients hospitalized, but a statistically significant decrease in the proportion of IBD patients undergoing surgery, from 10 to 8.8% (p < 0.001) for CD and 7.7 to 7.5% (p < 0.001) for UC. From 2014 through 2017, the proportion of urgent surgeries remained stable around 25% (p = 0.16) for CD and decreased from 21 to 14% (p < 0.001) for UC. For CD, the rate of post-operative 30-day mortality varied between 1.2 and 1.6% and for UC decreased from 5.8 to 2.3% (p < 0.001).ConclusionsAnalysis of a nationwide dataset from 2010 to 2017 determined that despite an increase in total admissions for IBD, a smaller proportion of hospitalized patients underwent surgery. A greater proportion of surgeries for UC were performed on an elective basis, and overall the rates of post-operative mortality for CD and UC decreased. The growth of biologic medical therapy during the study period highlights a probable contributing factor for the observed changes. More... »

PAGES

211-219

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11605-020-04832-y

DOI

http://dx.doi.org/10.1007/s11605-020-04832-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1132267758

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33140318


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colitis, Ulcerative", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Crohn Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Inflammatory Bowel Diseases", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, 757 Westwood Plaza, 90095, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, 757 Westwood Plaza, 90095, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lowe", 
        "givenName": "Sarina C.", 
        "id": "sg:person.016136470347.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016136470347.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sauk", 
        "givenName": "Jenny S.", 
        "id": "sg:person.0734646245.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734646245.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Limketkai", 
        "givenName": "Berkeley N.", 
        "id": "sg:person.0652343030.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652343030.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.19006.3e", 
          "name": [
            "Department of Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kwaan", 
        "givenName": "Mary R.", 
        "id": "sg:person.0636365046.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636365046.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ajg.2014.297", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000721324", 
          "https://doi.org/10.1038/ajg.2014.297"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2018.27", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101781143", 
          "https://doi.org/10.1038/ajg.2018.27"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2017.394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092458070", 
          "https://doi.org/10.1038/ajg.2017.394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11605-016-3275-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034500222", 
          "https://doi.org/10.1007/s11605-016-3275-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-11-02", 
    "datePublishedReg": "2020-11-02", 
    "description": "BackgroundMedical therapy for inflammatory bowel disease (IBD) has markedly advanced since the introduction of biologic therapeutics, although surgery remains an important therapeutic strategy for both Crohn\u2019s disease (CD) and ulcerative colitis (UC). This study evaluated how rates of bowel resection surgery and post-operative mortality for IBD have changed over the last decade in the era of biologic therapies.MethodsThe Nationwide Readmission Database (NRD) was queried for patients with IBD (based on ICD-9 and -10 diagnosis and procedure codes) who were hospitalized between 2010 and 2017. Longitudinal trends in bowel resection surgery, urgent surgery, and post-operative mortality were analyzed.ResultsDuring the 8-year period, a total of 1795,266 IBD-related hospitalizations (1,072,110 with CD and 723,156 with UC) were evaluated. There was an increase in the annual number of IBD patients hospitalized, but a statistically significant decrease in the proportion of IBD patients undergoing surgery, from 10 to 8.8% (p\u00a0<\u20090.001) for CD and 7.7 to 7.5% (p\u00a0<\u20090.001) for UC. From 2014 through 2017, the proportion of urgent surgeries remained stable around 25% (p\u00a0=\u20090.16) for CD and decreased from 21 to 14% (p\u00a0<\u20090.001) for UC. For CD, the rate of post-operative 30-day mortality varied between 1.2 and 1.6% and for UC decreased from 5.8 to 2.3% (p\u00a0<\u20090.001).ConclusionsAnalysis of a nationwide dataset from 2010 to 2017 determined that despite an increase in total admissions for IBD, a smaller proportion of hospitalized patients underwent surgery. A greater proportion of surgeries for UC were performed on an elective basis, and overall the rates of post-operative mortality for CD and UC decreased. The growth of biologic medical therapy during the study period highlights a probable contributing factor for the observed changes.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11605-020-04832-y", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1116755", 
        "issn": [
          "1091-255X", 
          "1873-4626"
        ], 
        "name": "Journal of Gastrointestinal Surgery", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "keywords": [
      "inflammatory bowel disease", 
      "post-operative mortality", 
      "bowel resection surgery", 
      "Nationwide Readmissions Database", 
      "ulcerative colitis", 
      "Crohn's disease", 
      "urgent surgery", 
      "IBD patients", 
      "biologic therapy", 
      "bowel disease", 
      "resection surgery", 
      "MethodsThe Nationwide Readmissions Database", 
      "rate of surgery", 
      "important therapeutic strategy", 
      "medical therapy", 
      "total admissions", 
      "elective basis", 
      "therapeutic strategies", 
      "surgery", 
      "patients", 
      "therapy", 
      "mortality", 
      "biologic therapeutics", 
      "disease", 
      "study period", 
      "significant decrease", 
      "annual number", 
      "longitudinal trends", 
      "greater proportion", 
      "nationwide dataset", 
      "small proportion", 
      "proportion", 
      "colitis", 
      "hospitalization", 
      "admission", 
      "rate", 
      "period", 
      "total", 
      "therapeutics", 
      "increase", 
      "observed changes", 
      "ConclusionsAnalysis", 
      "last decade", 
      "factors", 
      "decrease", 
      "database", 
      "study", 
      "changes", 
      "era", 
      "strategies", 
      "number", 
      "decades", 
      "trends", 
      "growth", 
      "introduction", 
      "basis", 
      "dataset"
    ], 
    "name": "Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy", 
    "pagination": "211-219", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1132267758"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11605-020-04832-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33140318"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11605-020-04832-y", 
      "https://app.dimensions.ai/details/publication/pub.1132267758"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_859.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11605-020-04832-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11605-020-04832-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11605-020-04832-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11605-020-04832-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11605-020-04832-y'


 

This table displays all metadata directly associated to this object as RDF triples.

183 TRIPLES      21 PREDICATES      92 URIs      80 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11605-020-04832-y schema:about N07c0d5b8acaf47c3a20dd410bda2153f
2 N689f8ce34af045709647ea04a0706f41
3 N88044fc9751146d9ba65ff5193e97d00
4 Na7b506437d5249c997e444374104632f
5 Nb63811dc3f004842aae92e4af386468b
6 Nc909a37b0c224ff3a1a109bc1e545db7
7 anzsrc-for:11
8 anzsrc-for:1103
9 schema:author N3473fda4f9464d71a03b38a718bac8dc
10 schema:citation sg:pub.10.1007/s11605-016-3275-z
11 sg:pub.10.1038/ajg.2014.297
12 sg:pub.10.1038/ajg.2017.394
13 sg:pub.10.1038/ajg.2018.27
14 schema:datePublished 2020-11-02
15 schema:datePublishedReg 2020-11-02
16 schema:description BackgroundMedical therapy for inflammatory bowel disease (IBD) has markedly advanced since the introduction of biologic therapeutics, although surgery remains an important therapeutic strategy for both Crohn’s disease (CD) and ulcerative colitis (UC). This study evaluated how rates of bowel resection surgery and post-operative mortality for IBD have changed over the last decade in the era of biologic therapies.MethodsThe Nationwide Readmission Database (NRD) was queried for patients with IBD (based on ICD-9 and -10 diagnosis and procedure codes) who were hospitalized between 2010 and 2017. Longitudinal trends in bowel resection surgery, urgent surgery, and post-operative mortality were analyzed.ResultsDuring the 8-year period, a total of 1795,266 IBD-related hospitalizations (1,072,110 with CD and 723,156 with UC) were evaluated. There was an increase in the annual number of IBD patients hospitalized, but a statistically significant decrease in the proportion of IBD patients undergoing surgery, from 10 to 8.8% (p < 0.001) for CD and 7.7 to 7.5% (p < 0.001) for UC. From 2014 through 2017, the proportion of urgent surgeries remained stable around 25% (p = 0.16) for CD and decreased from 21 to 14% (p < 0.001) for UC. For CD, the rate of post-operative 30-day mortality varied between 1.2 and 1.6% and for UC decreased from 5.8 to 2.3% (p < 0.001).ConclusionsAnalysis of a nationwide dataset from 2010 to 2017 determined that despite an increase in total admissions for IBD, a smaller proportion of hospitalized patients underwent surgery. A greater proportion of surgeries for UC were performed on an elective basis, and overall the rates of post-operative mortality for CD and UC decreased. The growth of biologic medical therapy during the study period highlights a probable contributing factor for the observed changes.
17 schema:genre article
18 schema:isAccessibleForFree false
19 schema:isPartOf N3ddce94dd0014c2b8198ee94b021977d
20 N67c5bce61fee44d49d575604e4ca6db7
21 sg:journal.1116755
22 schema:keywords ConclusionsAnalysis
23 Crohn's disease
24 IBD patients
25 MethodsThe Nationwide Readmissions Database
26 Nationwide Readmissions Database
27 admission
28 annual number
29 basis
30 biologic therapeutics
31 biologic therapy
32 bowel disease
33 bowel resection surgery
34 changes
35 colitis
36 database
37 dataset
38 decades
39 decrease
40 disease
41 elective basis
42 era
43 factors
44 greater proportion
45 growth
46 hospitalization
47 important therapeutic strategy
48 increase
49 inflammatory bowel disease
50 introduction
51 last decade
52 longitudinal trends
53 medical therapy
54 mortality
55 nationwide dataset
56 number
57 observed changes
58 patients
59 period
60 post-operative mortality
61 proportion
62 rate
63 rate of surgery
64 resection surgery
65 significant decrease
66 small proportion
67 strategies
68 study
69 study period
70 surgery
71 therapeutic strategies
72 therapeutics
73 therapy
74 total
75 total admissions
76 trends
77 ulcerative colitis
78 urgent surgery
79 schema:name Declining Rates of Surgery for Inflammatory Bowel Disease in the Era of Biologic Therapy
80 schema:pagination 211-219
81 schema:productId N8d532bfc9f854bb0a22f57ca587b1a2b
82 Na2b8cbabd5084fdcb9baf06df83ac52c
83 Ndf40bd0186f04cf1bfe3a9365b36983b
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132267758
85 https://doi.org/10.1007/s11605-020-04832-y
86 schema:sdDatePublished 2022-09-02T16:05
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher Nb544ed221bc343b1b2626dc006c091a4
89 schema:url https://doi.org/10.1007/s11605-020-04832-y
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N07c0d5b8acaf47c3a20dd410bda2153f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Humans
95 rdf:type schema:DefinedTerm
96 N3473fda4f9464d71a03b38a718bac8dc rdf:first sg:person.016136470347.52
97 rdf:rest Ndd372cbe7ef84f2ba176a6f0f600a449
98 N3ddce94dd0014c2b8198ee94b021977d schema:issueNumber 1
99 rdf:type schema:PublicationIssue
100 N4cb8ddea70d1418a8aaac326f87edc89 rdf:first sg:person.0636365046.18
101 rdf:rest rdf:nil
102 N537122c5e7104fc4974d06640059e606 rdf:first sg:person.0652343030.67
103 rdf:rest N4cb8ddea70d1418a8aaac326f87edc89
104 N67c5bce61fee44d49d575604e4ca6db7 schema:volumeNumber 25
105 rdf:type schema:PublicationVolume
106 N689f8ce34af045709647ea04a0706f41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Colitis, Ulcerative
108 rdf:type schema:DefinedTerm
109 N88044fc9751146d9ba65ff5193e97d00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Crohn Disease
111 rdf:type schema:DefinedTerm
112 N8d532bfc9f854bb0a22f57ca587b1a2b schema:name dimensions_id
113 schema:value pub.1132267758
114 rdf:type schema:PropertyValue
115 Na2b8cbabd5084fdcb9baf06df83ac52c schema:name doi
116 schema:value 10.1007/s11605-020-04832-y
117 rdf:type schema:PropertyValue
118 Na7b506437d5249c997e444374104632f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Biological Therapy
120 rdf:type schema:DefinedTerm
121 Nb544ed221bc343b1b2626dc006c091a4 schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 Nb63811dc3f004842aae92e4af386468b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Colitis
125 rdf:type schema:DefinedTerm
126 Nc909a37b0c224ff3a1a109bc1e545db7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Inflammatory Bowel Diseases
128 rdf:type schema:DefinedTerm
129 Ndd372cbe7ef84f2ba176a6f0f600a449 rdf:first sg:person.0734646245.51
130 rdf:rest N537122c5e7104fc4974d06640059e606
131 Ndf40bd0186f04cf1bfe3a9365b36983b schema:name pubmed_id
132 schema:value 33140318
133 rdf:type schema:PropertyValue
134 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
135 schema:name Medical and Health Sciences
136 rdf:type schema:DefinedTerm
137 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
138 schema:name Clinical Sciences
139 rdf:type schema:DefinedTerm
140 sg:journal.1116755 schema:issn 1091-255X
141 1873-4626
142 schema:name Journal of Gastrointestinal Surgery
143 schema:publisher Springer Nature
144 rdf:type schema:Periodical
145 sg:person.016136470347.52 schema:affiliation grid-institutes:grid.19006.3e
146 schema:familyName Lowe
147 schema:givenName Sarina C.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016136470347.52
149 rdf:type schema:Person
150 sg:person.0636365046.18 schema:affiliation grid-institutes:grid.19006.3e
151 schema:familyName Kwaan
152 schema:givenName Mary R.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636365046.18
154 rdf:type schema:Person
155 sg:person.0652343030.67 schema:affiliation grid-institutes:grid.19006.3e
156 schema:familyName Limketkai
157 schema:givenName Berkeley N.
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652343030.67
159 rdf:type schema:Person
160 sg:person.0734646245.51 schema:affiliation grid-institutes:grid.19006.3e
161 schema:familyName Sauk
162 schema:givenName Jenny S.
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734646245.51
164 rdf:type schema:Person
165 sg:pub.10.1007/s11605-016-3275-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1034500222
166 https://doi.org/10.1007/s11605-016-3275-z
167 rdf:type schema:CreativeWork
168 sg:pub.10.1038/ajg.2014.297 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000721324
169 https://doi.org/10.1038/ajg.2014.297
170 rdf:type schema:CreativeWork
171 sg:pub.10.1038/ajg.2017.394 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092458070
172 https://doi.org/10.1038/ajg.2017.394
173 rdf:type schema:CreativeWork
174 sg:pub.10.1038/ajg.2018.27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101781143
175 https://doi.org/10.1038/ajg.2018.27
176 rdf:type schema:CreativeWork
177 grid-institutes:grid.19006.3e schema:alternateName Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, USA
178 Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, 757 Westwood Plaza, 90095, Los Angeles, CA, USA
179 Department of Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA
180 schema:name Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA, USA
181 Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, 757 Westwood Plaza, 90095, Los Angeles, CA, USA
182 Department of Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA
183 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...